NEW YORK (GenomeWeb News) – Lophius Biosciences today announced that it has raised €1.4 million ($2 million) in a round of private financing.
The Regensburg, Germany-based startup is developing T-cell-based diagnostics and also provides cell-based assay testing for pharmaceuticals.
It said that the funds will be used to support the launch of its T-Track CMV/EBV tests in the transplantation field. The firm also said that it will use the proceeds to further develop a test for differential diagnosis of tuberculosis and a test for multiple sclerosis.
Lophius' existing investors, S-Refit and High-Tech Grϋnderfonds, and Bayernkapital participated in the financing round.